Two Hypoabsorption Techniques for the Treatment of Type III Obesity (OASIS) (OASIS)

July 10, 2023 updated by: Consorci Sanitari Integral

Randomized Prospective Study Comparing Two Hypoabsorption Techniques for the Treatment of Type III Obesity (Body Mass Index Between 45 - 49.9 Kg/m2): Single Anastomose Duodenal Switch (SADI-S) and Single Anastomose Gastric By-pass (OAGBP)

This study aims to compare the percentage of total weight lost in long-term follow-up after two surgical interventions (SADIS and OAGB) in patients with morbid obesity BMI between 45-49.9.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients over 18 and under 65 who meet criteria for bariatric surgery.
  • Maximum BMI between 45 and 50 kg/m2 and indication for surgery in a time
  • Signature of the informed consent of the study
  • Patients suitable for laparoscopic surgery

Exclusion Criteria:

  • Previous bariatric surgery
  • 2-stage surgery
  • Contraindication for hypoabsorptive surgery due to previous pathology: inflammatory bowel disease, transplant recipient or transplant candidate, previous intestinal resection surgery
  • Other associated surgical procedures in the same intervention.
  • Conversion to laparotomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A: SADI-S
SINGLE ANASTOMOSE DUODENAL SWITCH
TWO HYPOABSORPTION TECHNIQUES FOR THE TREATMENT OF TYPE III OBESITY (BODY MASS INDEX BETWEEN 45 - 49.9 KG/M2): SINGLE ANASTOMOSE DUODENAL SWITCH (SADI-S) AND SINGLE ANASTOMOSE GASTRIC BY-PASS (OAGBP).
Active Comparator: Group B: OAGB
SINGLE ANASTOMOSE GASTRIC BY-PASS
TWO HYPOABSORPTION TECHNIQUES FOR THE TREATMENT OF TYPE III OBESITY (BODY MASS INDEX BETWEEN 45 - 49.9 KG/M2): SINGLE ANASTOMOSE DUODENAL SWITCH (SADI-S) AND SINGLE ANASTOMOSE GASTRIC BY-PASS (OAGBP).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the percentage of total weight loss (%TWL) of the patients after surgery
Time Frame: Baseline, 1 year, 3 year, 5 year after SADI-S and OAGBP surgery
Baseline, 1 year, 3 year, 5 year after SADI-S and OAGBP surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% of patients with gastroesophageal reflux (acid and bile) after surgery
Time Frame: 1 year, 3 year, 5 year after SADI-S and OAGBP surgery
1 year, 3 year, 5 year after SADI-S and OAGBP surgery
Number of deaths in the immediate postoperative period
Time Frame: up to day 90 post-intervention
up to day 90 post-intervention
Number of Participants with complications in the immediate postoperative period
Time Frame: up to day 90 post-intervention
up to day 90 post-intervention
Ratio of patients with more than 3 loose stools per day
Time Frame: 1 year, 3 years, 5 years after the surgery
The ratio of patients with more than 3 loose stools per day will be evaluated as pathological. To assess the quality of the bowel movements, the Bristol Stool Form Scale questionnaire will be used. An evaluation of the number of bowel movements and their quality according to the Bristol Stool Form Scale questionnaire will be conducted at 1 year, 3 years, and 5 years after the surgery
1 year, 3 years, 5 years after the surgery
questionnaire of quality of life
Time Frame: 1 year, 3 years, 5 years after SADI-S and OAGBP surgery

The quality of life will be assessed based on the results of the Moorehead-Ardelt II test and the Medical Outcomes Study Short Form-36 questionnaire. The Moorehead-Ardelt II questionnaire includes 6 parameters related to self-esteem, physical activity, social contact, job satisfaction, sexual pleasure, and eating habits. The minimum score is -3 and the maximum is +3. A score of 1.1 to 2 is considered a good result, and anything above 2.1 is considered very good.

The SF-36 questionnaire includes 8 parameters such as physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role, and mental health. The minimum score is 0 and the maximum is 100.

1 year, 3 years, 5 years after SADI-S and OAGBP surgery
Number of patients with nutritional deficiencies
Time Frame: 1 year, 3 years, 5 years after SADI-S and OAGBP surgery

The main nutritional deficiencies to be evaluated after OAGB (One Anastomosis Gastric Bypass) and SADIS (Single Anastomosis Duodeno-Ileal Switch) are iron and/or vitamin B12 deficiency anemia, deficiencies in fat-soluble vitamins, calcium, and trace elements.

The incidence of nutritional deficiencies will be assessed through routine blood tests at 1 year, 3 years, and 5 years after the surgery

1 year, 3 years, 5 years after SADI-S and OAGBP surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2023

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

July 1, 2029

Study Registration Dates

First Submitted

June 12, 2023

First Submitted That Met QC Criteria

July 10, 2023

First Posted (Actual)

July 17, 2023

Study Record Updates

Last Update Posted (Actual)

July 17, 2023

Last Update Submitted That Met QC Criteria

July 10, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 23/001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Morbid

Clinical Trials on metabolic surgery (SADIS and OAGB)

Subscribe